Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by pidukson Jul 09, 2024 12:09pm
135 Views
Post# 36124551

Dave, as a non-doctor, non-scientist, you should

Dave, as a non-doctor, non-scientist, you should still be made aware of the inflamatory fighting capabilities of inhaled CBD into the lung structure of humans.   Rather than wasting your time promoting your deal with Remidose to entertain your retail segment you should instead, if you are any type of leadership CEO material, focusing on the more urgent health care applications to assist doctors.   That part I know you understand being a former sales and marketing employee at Purdue and driving their sales of oxycotin.   

A detailed study conducted by the University of Wisconsin-Madison revealed that the strain of H5N1 found in cattle can attach to receptors in the human respiratory tract, a characteristic not previously observed in the avian version of the virus.

Having learned a difficult once Dave, you should know by now it's all about setting your priorities and not just to line your own pocket with more bonuses.  
<< Previous
Bullboard Posts
Next >>